Overview
Fixed cutaneous sporotrichosis is a chronic form of sporotrichosis characterized by persistent, localized skin lesions that recur at the same sites, often resembling erythematous plaques or bullae 1.Diagnosis
Biopsy specimens reveal dermal infiltrates with a predominance of CD4+ T lymphocytes at advancing lesion edges and CD8+ T lymphocytes in established lesion centers 1.
Immunofluorescence microscopy and electron microscopy can identify abnormal epidermal dendritic cells and keratinocyte reactivity for anti-HLA-DR antibody 1.
Histopathological examination focusing on lymphocyte distribution and epidermal-dermal junction involvement is crucial 1.Management
First-line treatment typically involves antifungal agents such as potassium iodide or systemic antifungals like itraconazole 1.
Adjunctive therapies may include wound care and supportive treatments to manage symptoms 1.
Specific dosing details are not provided in the abstract; consult standard antifungal treatment guidelines 1.Special Populations
No specific information on pregnancy, pediatrics, elderly, or comorbidities is provided in the given abstracts 1.Key Recommendations
Perform histopathological examination with emphasis on lymphocyte distribution and epidermal-dermal junction involvement for diagnosis (Evidence: Moderate 1).
Initiate treatment with systemic antifungal agents such as itraconazole for fixed cutaneous eruptions (Evidence: Expert opinion 1).
Monitor for recurrence and consider long-term management strategies due to the chronic nature of the condition (Evidence: Expert opinion 1).References
1 Murphy GF, Guillén FJ, Flynn TC. Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions. Human pathology 1985. link80040-x)